On February 16th, 2022, the Reducing Hereditary Cancer Act (S.3656) was introduced to the U.S. Senate with the goal of ensuring Medicare beneficiaries have coverage for potentially life-saving inherited cancer genetic counseling and testing as well as recommended screening and risk-reducing procedures, when medically necessary and appropriate. Currently, Medicare only covers genetic testing for beneficiaries already diagnosed with cancer, regardless of whether there is cancer or a known genetic mutation in the family. Therefore, if someone without cancer is found to have an inherited mutation that increases cancer risk (e.g., BRCA1/2), Medicare may not cover the recommended cancer screenings and/or risk-reducing surgeries. Help ensure these life-saving services are accessible to Medicare patients by emailing members of Congress to ask them to support this important bill at https://tinyurl.com/RHCACQ. For more information about this bill, please visit https://tinyurl.com/BillS3656 and https://tinyurl.com/FORCERHCA.
Permanent link to this article: https://inheritedcancer.net/icare-newsletter-spring-2022-reducing-hereditary-cancer-act-of-2021/